VAT Trap Blog

Learn how to measure your waist correctly using anatomical landmarks to better assess visceral fat and cardiometabolic risk.

GLP-1 therapies reduce cardiovascular events, likely through visceral adipose tissue reduction, reframing cardiology treatment toward upstream metabolic disease targeting

Visceral fat sits silently behind heart disease, dementia, prediabetes, joint pain and aggressive prostate cancer risk

If the pharmacological effects of GLP-1 drugs disappear within weeks, why does the weight rebound take years? And how can that gap be used as a permanent metabolic reset? Written by Dr Edward Leatham, Consultant Cardiologist © 2026 E. Leatham VAT-TRAP Series Key Clinical Findings 1 1 Weight regain is slow despite rapid drug clearance. GLP-1 pharmacological effects fade within weeks, yet full weight rebound takes an average of 1.7 years — because body weight is biologically d